A phase 2 study of Daratumumab with Thalidomide and dexamethasone in relapsed and/or Refractory Myeloma (RRMM). - Nagarajan C; Jen WY; Ooi M; De Mel S; Soekojo C; Yoon SS; Tan M; Chen Y; Li X; Pokharkar Y; Tham SN; Hashim NSB; et al. (Blood cancer journal, 2025)